Log in to save to my catalogue

Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes

Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_899140485

Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes

About this item

Full title

Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes

Publisher

Cambridge, UK: Cambridge University Press

Journal title

The international journal of neuropsychopharmacology, 2010-07, Vol.13 (6), p.793-798

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Antipsychotic drugs are the best means available for symptomatically treating individuals suffering from schizophrenia; however, there is a significant variability in clinical response to these psychotropic medications. Previous findings connect oxytocin (OXT) with schizophrenia and antipsychotic action. Therefore, we evaluated if OXT and OXT recep...

Alternative Titles

Full title

Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_899140485

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_899140485

Other Identifiers

ISSN

1461-1457,1469-5111

E-ISSN

1469-5111

DOI

10.1017/S1461145710000167

How to access this item